González GG

Language: Spanish
References: 7
Page: 60-61
PDF size: 85.34 Kb.

REFERENCES

1. Reys DS. Spectra Optia^® apheresis system terapeutic plasma exchange (TPE): unlocking the potential of blood. literature Review.

2. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue. J Clin Apher. 2019; 34 (3): 171-354.

3. Cortese I, Chaudhry V, So YT, Cantor F, Cornblath DR, Rae-Grant A. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011; 76 (3): 294-300.

4. Navarro-Martínez R, Cauli O. Therapeutic plasmapheresis with albumin replacement in alzheimer's disease and chronic progressive multiple sclerosis: a review. Pharmaceuticals (Basel). 2020; 13 (2): 28. doi: 10.3390/ph13020028.

5. Khatri BO, McQuillen MP, Harrington GJ, Schmoll D, Hoffmann RG. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs. Neurology. 1985; 35 (3): 312-319.

6. Lipphardt M, Wallbach M, Koziolek MJ. Plasma exchange or immunoadsorption in demyelinating diseases: a meta-analysis. J Clin Med. 2020; 9 (5): 1597.

7. Blechinger S, Ehler J, Bsteh G, Winkelmann A, Leutmezer F, Meister S, et al. Therapeutic plasma exchange in steroid-refractory multiple sclerosis relapses. A retrospective two-center study. Ther Adv Neurol Disord. 2021; 14: 1756286420975642.